Beta
39330

Assessment of CTACK in sera of psoriatic patients, undergoing puva or methotrexate therapy

Thesis

Last updated: 06 Feb 2023

Subjects

-

Tags

Dermatology

Advisors

Sharaf, Amr E. , El-Gouhari, Sumaya M. , Tawfiq, Sherin U.

Authors

Abdel-Hamid, Abir Abdel-Halim

Accessioned

2017-04-26 12:37:40

Available

2017-04-26 12:37:40

type

M.D. Thesis

Abstract

Background: The cutaneous T cell attracting chemokine(CTACK/CCL27) is a pivotal chemokine in mediating lymphocytemigration into the skin, through the binding to the chemokinereceptor CCR10. The infiltration of skin by T cell appears to becrucial for the initiation and maintenance of inflammatory andautoimmune skin diseases, such as psoriasis.Objective: The aim of this study was to investigate the role ofCTACK in T cell homing in psoriasis. Which is a T cell mediateddisease.Patients and methods: This study included 30 patients withchronic plaque psoriasis and 30 healthy controls, in which wemeasured CTACK in the serum before and after therapy, [15patients received PUVA therapy and 15 received methotrexate].Results: CTACK level was significantly higher in patients thancontrols pretreatment [P value=0.001] such level decreasedsignificantly after treatment in both groups [ P value<0.05].Although both serum CTACK and PASI score decreased posttreatment , we could not detect a significant correlation, this wasalso true for pretreatment assessment, [P value> 0.05].Conclusion: CTACK might be significantly involved in thepathogenesis of psoriasis via mediating the migration oflymphocytes into the skin.

Issued

1 Jan 2009

DOI

http://dx.doi.org/10.21473/iknito-space/33274

Details

Type

Thesis

Created At

28 Jan 2023